Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D S Alberts

Showing results (51-60 of 366) with videos related to

Pageof 37
Sort By:
Cancer Research|June 1, 1981
Modulation of experimental doxorubicin skin toxicity by beta-adrenergic compoundsR T Dorr, D S Alberts
Cancer|September 1, 1992
Primary prevention of colorectal cancer through dietary modificationP A Vargas, D S Alberts
Seminars in Oncology|August 1, 1996
Future development of amifostine in cancer treatmentD S Alberts, W A Bleyer
Seminars in Oncology|August 1, 1989
The role of cisplatin in the management of advanced squamous cell cancer of the cervixD S Alberts, N Mason-Liddil
Cancer Research|August 1, 1976
The effect of allopurinol on cyclophosphamide antitumor activityD S Alberts, T van Daalen Wetters
British Journal of Cancer|July 1, 1976
Rubidazone vs adriamycin: an evaluation of their differential toxicity in the spleen colony assay systemD S Alberts, T Van Daalen Wetters
International Journal of Cancer|February 20, 1996
Genetic screening for colorectal cancer and interventionD S Alberts, M Lipkin, B Levin
Cancer Research|August 1, 1976
The effect of phenobarbital on cyclophosphamide antitumor activityD S Alberts, T van Daalen Wetters
Cancer Treatment Reports|May 1, 1986
Clinical toxicity of low-dose isotretinoinL Edwards, D S Alberts, N Levine
Cancer Treatment Reports|April 1, 1985
Cold protection and heat enhancement of doxorubicin skin toxicity in the mouseR T Dorr, D S Alberts, A Stone
Pageof 37

Showing results (51-60 of 366) with videos related to

Sort By:
Pageof 37
Cancer Research|June 1, 1981
Modulation of experimental doxorubicin skin toxicity by beta-adrenergic compoundsR T Dorr, D S Alberts
Cancer|September 1, 1992
Primary prevention of colorectal cancer through dietary modificationP A Vargas, D S Alberts
Seminars in Oncology|August 1, 1996
Future development of amifostine in cancer treatmentD S Alberts, W A Bleyer
Seminars in Oncology|August 1, 1989
The role of cisplatin in the management of advanced squamous cell cancer of the cervixD S Alberts, N Mason-Liddil
Cancer Research|August 1, 1976
The effect of allopurinol on cyclophosphamide antitumor activityD S Alberts, T van Daalen Wetters
British Journal of Cancer|July 1, 1976
Rubidazone vs adriamycin: an evaluation of their differential toxicity in the spleen colony assay systemD S Alberts, T Van Daalen Wetters
International Journal of Cancer|February 20, 1996
Genetic screening for colorectal cancer and interventionD S Alberts, M Lipkin, B Levin
Cancer Research|August 1, 1976
The effect of phenobarbital on cyclophosphamide antitumor activityD S Alberts, T van Daalen Wetters
Cancer Treatment Reports|May 1, 1986
Clinical toxicity of low-dose isotretinoinL Edwards, D S Alberts, N Levine
Cancer Treatment Reports|April 1, 1985
Cold protection and heat enhancement of doxorubicin skin toxicity in the mouseR T Dorr, D S Alberts, A Stone
Pageof 37